Allarity Therapeutics Inc. - נכסים נקיים למניה בודדת ALLR

The virtual business model of Allarity Therapeutics (ALLR), which relies on external contractors, creates high operational dependency. The book value per share ratio on the GURU.Markets chart illustrates the current capital vector, where the 0.22 indicator determines the parameter status. This is accompanied by the implementation of an AI platform to automate therapy selection, although the lack of stable revenue limits the company's pricing power.

Investors are assessing the resilience of Allarity Therapeutics (ALLR) through the book value per share, calculated as the difference between the company's total assets and liabilities divided by the number of outstanding securities. Analyzing the target book value per share provides insight into how effectively the biotech firm's capital is being deployed to develop its personalized cancer therapy platform and support partnerships with oncology centers.